NCT02784795 2025-08-21
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Eli Lilly and Company
Phase 1 Terminated
Clinical Trials
4 trialsNCT01226485 2019-09-13
A Study in Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT01919398 2019-09-11
A Study of LY2940680 in Japanese Participants With Advanced Cancers
Eli Lilly and Company
Phase 1 Completed
NCT01697514 2013-08-27
A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
Eli Lilly and Company
Phase 1 Withdrawn